Education
About Us
Working with TipRanks
Follow Us
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
RESEARCH TOOLSreports
Total Valuation
Praxis Precision Medicines has a market cap or net worth of $875.87M. The enterprise value is -$832.42K.
Market Cap$875.87M
Enterprise Value-$832.42K
Share Statistics
Praxis Precision Medicines has 20,368,982 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,368,982
Owned by Insiders10.75%
Owned by Institutions2.52%
Financial Efficiency
Praxis Precision Medicines’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -44.80%.
Return on Equity (ROE)-0.41
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-44.80%
Return on Capital Employed (ROCE)-0.45
Revenue Per Employee73.73K
Profits Per Employee-1.58M
Employee Count116
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Praxis Precision Medicines is -7.54. Praxis Precision Medicines’s PEG ratio is -0.09.
PE Ratio-7.54
PS Ratio0.00
PB Ratio1.06
Price to Fair Value3.09
Price to FCF-1.27
Price to Operating Cash Flow-1.27
PEG Ratio-0.09
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 8.55M and earned -182.82M in profits. Earnings per share was -10.21.
Revenue8.55M
Gross Profit8.20M
Operating Income-200.16M
Pretax Income-182.82M
Net Income-182.82M
EBITDA-199.81M
Earnings Per Share (EPS)-10.21
Cash Flow
In the last 12 months, operating cash flow was -163.91M and capital expenditures 64.00K, giving a free cash flow of -163.85M billion.
Operating Cash Flow-163.91M
Free Cash Flow-163.85M
Free Cash Flow per Share-8.04
Dividends & Yields
Praxis Precision Medicines pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.28
52-Week Price Change7.08%
50-Day Moving Average39.67
200-Day Moving Average57.81
Relative Strength Index (RSI)50.44
Average Volume (3m)282.49K
Important Dates
Praxis Precision Medicines upcoming earnings date is Aug 19, 2025, Before Open (Confirmed).
Last Earnings DateMay 2, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
Praxis Precision Medicines as a current ratio of 10.77, with Debt / Equity ratio of 3.64%
Current Ratio10.77
Quick Ratio10.77
Debt to Market Cap<0.01
Net Debt to EBITDA1.07
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Praxis Precision Medicines has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Praxis Precision Medicines EV to EBITDA ratio is -5.83, with an EV/FCF ratio of -8.84.
EV to Sales136.10
EV to EBITDA-5.83
EV to Free Cash Flow-8.84
EV to Operating Cash Flow-8.84
Balance Sheet
Praxis Precision Medicines has $327.99M in cash and marketable securities with $1.07M in debt, giving a net cash position of -$326.93M billion.
Cash & Marketable Securities$327.99M
Total Debt$1.07M
Net Cash-$326.93M
Net Cash Per Share-$16.05
Tangible Book Value Per Share$24.88
Margins
Gross margin is 0.00%, with operating margin of -2340.29%, and net profit margin of -2137.48%.
Gross Margin0.00%
Operating Margin-2340.29%
Pretax Margin-2137.48%
Net Profit Margin-2137.48%
EBITDA Margin-2336.10%
EBIT Margin-2340.29%
Analyst Forecast
The average price target for Praxis Precision Medicines is $111.13, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$111.13
Price Target Upside158.44% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast270.02%
EPS Growth Forecast32.69%